Vincerx Pharma, Inc.
VINCDelisted Apr 28, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001796129
Vincerx Pharma, Inc. was delisted on Apr 28, 2025; its insiders filed their last Form 4 on Aug 14, 2024; 14 institutions reported holding it in 13F filings for Q1 2025, worth $116.8K in total; no superinvestor held it.
Holders of 5% or more of VINC
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Vincerx Pharma, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Vincerx Pharma, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
5 Schedule 13D and 13G filings on Vincerx Pharma, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jul 29, 20255:55 PM ET | Sage Rhino Capital LLC | 13G/A | 0.00%4.26K shares | –Below 5% | Jan 29, 2025 | SEC |
| May 15, 20253:13 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 4.99%274.9K shares | −5.00 ppfrom 9.99%Below 5% | Mar 31, 2025 | SEC |
| Feb 14, 20255:22 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 9.99%4.48M shares | – | Dec 31, 2024 | SEC |
| Feb 12, 20258:30 AM ET | Prosight Management, LPand 4 others | 13G/A | 4.99%111.8K shares | –Below 5% | Dec 31, 2024 | SEC |
| Feb 11, 20257:09 PM ET | Long Focus Capital Management, LLCand 4 others | 13G/A | 0.00%0 shares | –Below 5% | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Vincerx Pharma, Inc. shares.
No Form 144 notices for Vincerx Pharma, Inc. are on file.